BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30951819)

  • 1. Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?
    Hu Y; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
    Eur J Pharm Biopharm; 2019 Jun; 139():197-204. PubMed ID: 30951819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study.
    Hu Y; Rip J; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
    J Pharm Sci; 2017 Sep; 106(9):2606-2613. PubMed ID: 28322936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study.
    Lindqvist A; Rip J; Gaillard PJ; Björkman S; Hammarlund-Udenaes M
    Mol Pharm; 2013 May; 10(5):1533-41. PubMed ID: 22934681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Quantitative Understanding of PEGylated Liposome's Influence on Brain Delivery of Diphenhydramine.
    Hu Y; Gaillard PJ; Rip J; de Lange ECM; Hammarlund-Udenaes M
    Mol Pharm; 2018 Dec; 15(12):5493-5500. PubMed ID: 30376346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
    Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
    Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
    Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
    J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats.
    Rip J; Chen L; Hartman R; van den Heuvel A; Reijerkerk A; van Kregten J; van der Boom B; Appeldoorn C; de Boer M; Maussang D; de Lange EC; Gaillard PJ
    J Drug Target; 2014 Jun; 22(5):460-7. PubMed ID: 24524555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes.
    Lindqvist A; Rip J; van Kregten J; Gaillard PJ; Hammarlund-Udenaes M
    Pharm Res; 2016 Jan; 33(1):177-85. PubMed ID: 26275529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier.
    Reginald-Opara JN; Tang M; Svirskis D; Chamley L; Wu Z
    Int J Pharm; 2022 Oct; 626():122152. PubMed ID: 36055442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
    Gaillard PJ; Appeldoorn CC; Rip J; Dorland R; van der Pol SM; Kooij G; de Vries HE; Reijerkerk A
    J Control Release; 2012 Dec; 164(3):364-9. PubMed ID: 22732475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
    Subasic CN; Butcher NJ; Minchin RF; Kaminskas LM
    Mol Pharm; 2023 Jul; 20(7):3494-3504. PubMed ID: 37256791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo.
    Maussang D; Rip J; van Kregten J; van den Heuvel A; van der Pol S; van der Boom B; Reijerkerk A; Chen L; de Boer M; Gaillard P; de Vries H
    Drug Discov Today Technol; 2016 Jun; 20():59-69. PubMed ID: 27986226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood-brain barrier.
    Wang X; Liu P; Yang W; Li L; Li P; Liu Z; Zhuo Z; Gao Y
    Int J Nanomedicine; 2014; 9():4899-909. PubMed ID: 25364248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations.
    Williams A; Goodfellow R; Topley N; Amos N; Williams B
    Inflamm Res; 2000 Apr; 49(4):155-61. PubMed ID: 10858015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,(®)/Doxil(®)--a cerebral open flow microperfusion pilot study.
    Birngruber T; Raml R; Gladdines W; Gatschelhofer C; Gander E; Ghosh A; Kroath T; Gaillard PJ; Pieber TR; Sinner F
    J Pharm Sci; 2014 Jul; 103(7):1945-1948. PubMed ID: 24801480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study.
    Salem HF; Ahmed SM; Hassaballah AE; Omar MM
    Drug Des Devel Ther; 2015; 9():3705-27. PubMed ID: 26229435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo methotrexate disposition in alveolar macrophages: comparison of pharmacokinetic parameters of two formulations.
    Doddoli C; Ghez O; Barlési F; D'journo B; Robitail S; Thomas P; Clerc T
    Int J Pharm; 2005 Jun; 297(1-2):180-9. PubMed ID: 15869851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma.
    Alekseeva AA; Moiseeva EV; Onishchenko NR; Boldyrev IA; Singin AS; Budko AP; Shprakh ZS; Molotkovsky JG; Vodovozova EL
    Int J Nanomedicine; 2017; 12():3735-3749. PubMed ID: 28553111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents].
    Kong SY; Tang GT; Pei YY; Jiang YY
    Yao Xue Xue Bao; 2009 Jan; 44(1):85-90. PubMed ID: 19350828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.